NOVELIX PHARMACEUTICALS LIMITE

NOVELIX

Small Cap | Pharmaceuticals
63.75
+1.27 (+2.03%)

Stock price as on 06 Feb 2026 at 15:16 PM

Novelix pharmaceuticals limite share price update

As of the latest trading session, Novelix Pharmaceuticals Limite share price is currently at ₹63.75, which is up by ₹1.27 from its previous closing. T...

Novelix Pharmaceuticals Limite stock performance

Today’s low

₹62

Today’s high

₹64.4

₹63.75

52 week low

₹25.35

52 week high

₹70.16

₹63.75
Open
₹63.73
Previous close
₹62.48
Share volume
1,051
Total traded value (Lakh)
₹0.66
Upper circuit
₹68.72
Lower circuit
₹56.24

Novelix Pharmaceuticals Limite fundamentals

Market cap (Cr)
₹112.30
P/E ratio (TTM)
115.91
Book value per share
₹18.09
Beta
0.56
Return on equity
0.56%
Earnings per share (TTM)
₹0.55
Dividend yield
0%
Net profit/quarter (Cr)
₹0.53

Novelix Pharmaceuticals Limite financials

(Values in Cr)
Revenue
Net income

Particulars

Sep 25 (₹ value in crores)

Revenue

₹36.36

Operating expense

₹35.67

Net income

₹0.53

Net profit margin

1.45%

Earning per share

₹0.37

EBITDA

₹0.73

Effective tax rate

26.38%

Particulars

Jun 25 (₹ value in crores)

Revenue

₹22.35

Operating expense

₹22.18

Net income

₹0.11

Net profit margin

0.49%

Earning per share

₹0.09

EBITDA

₹0.18

Effective tax rate

35.29%

Particulars

Mar 25 (₹ value in crores)

Revenue

₹20.86

Operating expense

₹20.65

Net income

₹0.18

Net profit margin

0.86%

Earning per share

₹0.18

EBITDA

₹0.22

Effective tax rate

14.28%

Particulars

Dec 24 (₹ value in crores)

Revenue

₹5.30

Operating expense

₹5.17

Net income

₹0.15

Net profit margin

2.83%

Earning per share

₹0.15

EBITDA

₹0.13

Effective tax rate

-15.38%

Particulars

Sep 24 (₹ value in crores)

Revenue

₹3.96

Operating expense

₹3.74

Net income

₹0.13

Net profit margin

3.28%

Earning per share

₹0.16

EBITDA

₹0.13

Effective tax rate

-

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Revenue

₹30.72

Operating expense

-

Net income

₹0.08

Net profit margin

0.26%

Earning per share

₹0.08

EBITDA

₹0.16

Effective tax rate

33.33%

Particulars

Mar 24 (₹ value in crores)

Revenue

₹4.22

Operating expense

₹4.51

Net income

₹0.01

Net profit margin

0.23%

Earning per share

₹0.01

EBITDA

₹0.06

Effective tax rate

50%

Particulars

Mar 23 (₹ value in crores)

Revenue

₹1.40

Operating expense

₹1.98

Net income

-₹0.06

Net profit margin

-4.28%

Earning per share

-₹0.07

EBITDA

-

Effective tax rate

-

Particulars

Mar 22 (₹ value in crores)

Revenue

₹0.84

Operating expense

₹2.96

Net income

-₹1.56

Net profit margin

-185.71%

Earning per share

-₹1.93

EBITDA

-₹1.50

Effective tax rate

0.63%

Particulars

Mar 21 (₹ value in crores)

Revenue

₹0.99

Operating expense

₹4.58

Net income

-₹3.27

Net profit margin

-330.3%

Earning per share

-₹4.04

EBITDA

-₹3.19

Effective tax rate

-

(Values in Cr)
Revenue
Net income

Particulars (annual)

Mar 22 (₹ value in crores)

Book value per share

₹9.14

Return on Equity (ROE)

-

Return on Capital Employed (ROCE)

-

Total debt to equity ratio

0.01

EBITDA margin

-20.22%

Particulars (annual)

Mar 21 (₹ value in crores)

Book value per share

₹8.47

Return on Equity (ROE)

-

Return on Capital Employed (ROCE)

-

Total debt to equity ratio

0.04

EBITDA margin

-36.18%

Particulars (annual)

Mar 20 (₹ value in crores)

Book value per share

₹13.09

Return on Equity (ROE)

-2.42%

Return on Capital Employed (ROCE)

-0.86%

Total debt to equity ratio

0.08

EBITDA margin

0.92%

Particulars (annual)

Mar 19 (₹ value in crores)

Book value per share

₹13.48

Return on Equity (ROE)

-1.54%

Return on Capital Employed (ROCE)

-0.93%

Total debt to equity ratio

0.09

EBITDA margin

1%

Particulars (annual)

Mar 18 (₹ value in crores)

Book value per share

₹13.79

Return on Equity (ROE)

-2.99%

Return on Capital Employed (ROCE)

-0.07%

Total debt to equity ratio

0.09

EBITDA margin

2.16%

(Values in Cr)
Revenue
Net income

Particulars (annual)

Mar 25 (₹ value in crores)

Book value per share

₹17.63

Return on Equity (ROE)

0.56%

Return on Capital Employed (ROCE)

0.84%

Total debt to equity ratio

-

EBITDA margin

0.52%

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

₹9.08

Return on Equity (ROE)

0.12%

Return on Capital Employed (ROCE)

0.24%

Total debt to equity ratio

-

EBITDA margin

1.42%

Particulars (annual)

Mar 23 (₹ value in crores)

Book value per share

₹8.88

Return on Equity (ROE)

-

Return on Capital Employed (ROCE)

-

Total debt to equity ratio

-

EBITDA margin

-

Particulars (annual)

Mar 22 (₹ value in crores)

Book value per share

₹8.94

Return on Equity (ROE)

-

Return on Capital Employed (ROCE)

-

Total debt to equity ratio

-

EBITDA margin

-107.19%

Particulars (annual)

Mar 21 (₹ value in crores)

Book value per share

₹10.87

Return on Equity (ROE)

-

Return on Capital Employed (ROCE)

-

Total debt to equity ratio

-

EBITDA margin

-243.51%

(Values in Cr)
Revenue
Net income

Particulars

Mar 22 (₹ value in crores)

Cash and short term investments

₹2.88

Total assets

₹8.73

Total liabilities

₹8.73

Total equity

₹7.67

Shares outstanding

₹0.81

Price to book ratio

₹0.99

Return on assets (%)

-20.6%

Return on capital

-23.05%

Particulars

Mar 21 (₹ value in crores)

Cash and short term investments

₹2.07

Total assets

₹9.57

Total liabilities

₹9.57

Total equity

₹7.36

Shares outstanding

₹0.81

Price to book ratio

₹0.62

Return on assets (%)

-39.06%

Return on capital

-50.77%

Particulars

Mar 20 (₹ value in crores)

Cash and short term investments

₹1.11

Total assets

₹13.72

Total liabilities

₹13.72

Total equity

₹11.12

Shares outstanding

₹0.81

Price to book ratio

₹0.13

Return on assets (%)

-2.06%

Return on capital

-2.38%

Particulars

Mar 19 (₹ value in crores)

Cash and short term investments

₹0.19

Total assets

₹13.34

Total liabilities

₹13.34

Total equity

₹11.42

Shares outstanding

₹0.81

Price to book ratio

-

Return on assets (%)

-1.81%

Return on capital

-1.96%

Particulars

Mar 18 (₹ value in crores)

Cash and short term investments

₹0.35

Total assets

₹13.57

Total liabilities

₹13.57

Total equity

₹11.57

Shares outstanding

₹0.81

Price to book ratio

₹0.52

Return on assets (%)

-2.56%

Return on capital

-2.77%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Cash and short term investments

₹0.67

Total assets

₹27.20

Total liabilities

₹27.20

Total equity

₹17.53

Shares outstanding

₹0.99

Price to book ratio

₹1.51

Return on assets (%)

0.31%

Return on capital

0.48%

Particulars

Mar 24 (₹ value in crores)

Cash and short term investments

₹0.11

Total assets

₹7.36

Total liabilities

₹7.36

Total equity

₹7.35

Shares outstanding

₹0.81

Price to book ratio

₹1.89

Return on assets (%)

0.14%

Return on capital

0.14%

Particulars

Mar 23 (₹ value in crores)

Cash and short term investments

₹0.27

Total assets

₹7.25

Total liabilities

₹7.25

Total equity

₹7.19

Shares outstanding

₹0.81

Price to book ratio

₹1.01

Return on assets (%)

-0.82%

Return on capital

-0.83%

Particulars

Mar 22 (₹ value in crores)

Cash and short term investments

₹2.60

Total assets

₹7.25

Total liabilities

₹7.25

Total equity

₹7.24

Shares outstanding

₹0.81

Price to book ratio

₹0.99

Return on assets (%)

-21.51%

Return on capital

-21.54%

Particulars

Mar 21 (₹ value in crores)

Cash and short term investments

₹1.73

Total assets

₹8.76

Total liabilities

₹8.76

Total equity

₹8.80

Shares outstanding

₹0.81

Price to book ratio

₹0.62

Return on assets (%)

-37.28%

Return on capital

-37.13%

(Values in Cr)
Revenue
Net income

Particulars

Mar 22 (₹ value in crores)

Net income

-₹2.12

Cash from operations

₹1.10

Cash from investing

-₹0.75

Cash from financing

-

Net change in cash

₹0.82

Free cash flow

₹2.90

Particulars

Mar 21 (₹ value in crores)

Net income

-₹3.72

Cash from operations

₹1.62

Cash from investing

₹0.13

Cash from financing

-₹0.76

Net change in cash

₹0.96

Free cash flow

₹1.64

Particulars

Mar 20 (₹ value in crores)

Net income

-₹0.21

Cash from operations

₹0.73

Cash from investing

₹0.45

Cash from financing

-₹0.16

Net change in cash

₹0.91

Free cash flow

₹0.83

Particulars

Mar 19 (₹ value in crores)

Net income

-₹0.12

Cash from operations

-₹0.52

Cash from investing

₹0.42

Cash from financing

-₹0.04

Net change in cash

-₹0.15

Free cash flow

-₹0.38

Particulars

Mar 18 (₹ value in crores)

Net income

-₹0.30

Cash from operations

₹0.49

Cash from investing

-₹0.63

Cash from financing

₹0.02

Net change in cash

-₹0.24

Free cash flow

₹0.86

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Net income

₹0.12

Cash from operations

-₹13.68

Cash from investing

₹2.93

Cash from financing

₹11.31

Net change in cash

₹0.56

Free cash flow

-₹13.57

Particulars

Mar 24 (₹ value in crores)

Net income

₹0.02

Cash from operations

-₹0.34

Cash from investing

₹0.18

Cash from financing

-

Net change in cash

-₹0.15

Free cash flow

-₹0.34

Particulars

Mar 23 (₹ value in crores)

Net income

-₹0.05

Cash from operations

-₹2.40

Cash from investing

₹0.07

Cash from financing

-

Net change in cash

-₹2.33

Free cash flow

-₹2.40

Particulars

Mar 22 (₹ value in crores)

Net income

-₹1.56

Cash from operations

₹0.59

Cash from investing

₹0.27

Cash from financing

-

Net change in cash

₹0.86

Free cash flow

₹2.45

Particulars

Mar 21 (₹ value in crores)

Net income

-₹3.27

Cash from operations

₹0.58

Cash from investing

₹0.20

Cash from financing

-

Net change in cash

₹0.78

Free cash flow

₹0.88

Novelix Pharmaceuticals Limite technical summary

₹63.75
+ 2.03 ▲
16
Bearish
0
Bullish
5 Day62.1
10 Day60.8
12 Day60.4
20 Day59.5
26 Day59.1
50 Day57.8
100 Day53.5
200 Day44.9
5 Day61.9
10 Day60.8
12 Day59.9
20 Day57.7
26 Day58.3
50 Day59
100 Day53.4
200 Day43.9

61.83

PIVOT

First support
₹61.15
First resistance
₹63.15
Second support
₹59.83
Second resistance
₹63.83
Third support
₹59.15
Third resistance
₹65.15
RSI
63.54
ADX
35.18
MACD
1.25
Williams % R
-5.68
Commodity Channel Index (CCI)
124
Date
06 Feb 2026
Same day
1,050
Week
6,796
Month
7,728
1 year
0.57
3 years
0.2
Over 1 month
7.14%
Over 1 year
151.47%
Over 3 months
21.31%
Over 3 years
80.33%
Over 6 months
58.38%
Over 6 years
70.15%

Investment Returns

Over 1 Month7.14%
Over 3 Months21.31%
Over 6 Months58.38%
Over 1 Year151.47%

Novelix Pharmaceuticals Limite Shareholding pattern


Public
49.2%
Promoter holdings
50.79%
FII
0%
DII
0%
Promoter shares
0%
Promoter sharesShareCategory

Srinidhi Fine-chemicals Llp

60,02,000 (34.07%)

Shareholding of Promoter and Promoter Group

Vupparapalli Chandrasekhar Reddy

15,70,733 (8.92%)

Shareholding of Promoter and Promoter Group

Mallela Venkatramna Reddy

15,00,000 (8.52%)

Public Shareholding

Sesha Sai Nikhil Chintalapati

9,68,000 (5.5%)

Public Shareholding

Srinivasrao Swetha Kanakapur

8,67,000 (4.92%)

Public Shareholding

Promoter sharesShareCategory
Srinidhi Fine-chemicals Llp60,02,000 (34.07%)Shareholding of Promoter and Promoter Group
Vupparapalli Chandrasekhar Reddy15,70,733 (8.92%)Shareholding of Promoter and Promoter Group
Mallela Venkatramna Reddy15,00,000 (8.52%)Public Shareholding
Sesha Sai Nikhil Chintalapati9,68,000 (5.5%)Public Shareholding
Srinivasrao Swetha Kanakapur8,67,000 (4.92%)Public Shareholding
Narhari Belide6,00,000 (3.41%)Shareholding of Promoter and Promoter Group
Panchagnula Venkata Lakshmi Narayana Sankara Vara Prasad5,25,000 (2.98%)Public Shareholding
Vupparapalli Pavani4,00,000 (2.27%)Shareholding of Promoter and Promoter Group
Gattu Gnana Prakash3,50,000 (1.99%)Shareholding of Promoter and Promoter Group
Palakurthi Rakesh2,74,125 (1.56%)Public Shareholding
Soura Investments Holdings Private Limited2,70,000 (1.53%)Public Shareholding
Dm Fincon Services Llp2,50,000 (1.42%)Public Shareholding
Arpan Vipin Mantri2,00,000 (1.14%)Public Shareholding
Shyam Agarwal (huf)25,000 (0.14%)Shareholding of Promoter and Promoter Group

About NOVELIX PHARMACEUTICALS LIMITE

Trimurthi Limited was formerly incorporated on December 13, 1994 with the name Trimurthi Securities Ltd. The name of the Company thereafter got changed from Trimurthi Securities Ltd to Trimurthi Drugs & Pharmaceuticals Ltd. In September 2006, as per the Scheme of Arrangement, the erstwhile Trimurthi Drugs & Pharmaceuticals Ltd amalgamated with the Company. Also, the name of the Company was changed to Trimurthi Drugs & Pharmaceuticals Ltd and again to Trimurthi Limited in May, 2016. Initially, the company was engaged in finance and investment

Parent Organisation

Indian Private

NSE Symbol

NOVELIX PHARMACEUTICALS LIMITE

Founded

1994

NOVELIX PHARMACEUTICALS LIMITE CORPORATE ACTION

Dividend dateDividend amountDividend typeRecord dateInstrument type
16 Aug 20120.3Final21 Aug 2012Equity shares
22 Sept 20110.3Final25 Sept 2011Equity shares
23 Aug 20100.03Final25 Aug 2010Equity shares
01 Sept 20090.3Final03 Sept 2009Equity shares

View more stocks

What’s trending

All stocks

LOYALTEX

LOYAL TEXTILE MILLS LTD.

304.8
+50.8 (+20%)
GORANIN

GORANI INDUSTRIES LTD.

63.61
+10.6 (+20%)
NIRAJISPAT

NIRAJ ISPAT IND LTD

257.41
+42.9 (+20%)
STRATMONT

STRATMONT INDUSTRIES LIMITED

90.01
+15 (+20%)
View all

Top gainers

ITC

ITC LTD

325.8
+15.60 (+5.03%)
KOTAKBANK

KOTAK MAHINDRA BANK LTD

422.35
+13.60 (+3.33%)
HINDUNILVR

HINDUSTAN UNILEVER LTD.

2424.2
+69.80 (+2.96%)
BHARTIARTL

BHARTI AIRTEL LIMITED

2038.4
+46.00 (+2.31%)
View all

Top losers

HDFCLIFE

HDFC LIFE INS CO LTD

703.5
-17.20 (-2.39%)
TCS

TATA CONSULTANCY SERV LT

2941.6
-49.90 (-1.67%)
TECHM

TECH MAHINDRA LIMITED

1619.9
-26.30 (-1.60%)
BAJAJ-AUTO

BAJAJ AUTO LIMITED

9518.5
-128.50 (-1.33%)
View all

Frequently asked questions


Related videos


Related tags


You are here


Related links

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer


Powered by Bajaj Financial Securities Limited (Bajaj Broking)